Amanote Research
Register
Sign In
Healthcare Resource Use (HRU) in Hospitalized Patients With a Diagnosis of Spinal Muscular Atrophy Type 1 (SMA1): Retrospective Analysis of the Kids’ Inpatient Database (KID)
Value in Health
- United Kingdom
doi 10.1016/j.jval.2017.08.750
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2017
Authors
J Cardenas
M Menier
M Heitzer
D Sproule
Publisher
Elsevier BV
Related search
Economic Burden of Infant-Onset (Type 1) Spinal Muscular Atrophy: A Retrospective Claims Database Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pnd41 - Healthcare Costs of Patients With Spinal Muscular Atrophy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Spinal Muscular Atrophy Type 1
Pediatric Critical Care Medicine
Child Health
Critical Care
Pediatrics
Perinatology
Intensive Care Medicine
Patient Characteristics and Hospitalisation Costs of Spinal Muscular Atrophy in Spain: A Retrospective Multicentre Database Analysis
BMJ Open
Medicine
P.060 Time to Treatment Effect in Spinal Muscular Atrophy Type 1 (SMA1): An Indirect Comparison of Treatments
Canadian Journal of Neurological Sciences
Medicine
Neurology
Respiratory Management of the Infant With Type 1 Spinal Muscular Atrophy
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology
Spinal Muscular Atrophy With Respiratory Distress Type 1—A Child With Atypical Presentation
Child Neurology Open
Permissibility of Prenatal Diagnosis and Abortion for Fetuses With Severe Genetic Disorder: Type 1 Spinal Muscular Atrophy
Annals of Saudi Medicine
Medicine
066 Avxs-101 Gene-Replacement Therapy (GRT) for Spinal Muscular Atrophy Type 1 (SMA1): Pivotal Phase 3 Study (STR1VE) Update
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
